The Global Health Body Sounds Warning Over Critical Lack of Obesity Medications

Less than 10% of people eligible to benefit from obesity jabs such as Wegovy can access them, warns the World Health Organization as it releases its inaugural recommendations on the therapies.

Considering over a billion individuals worldwide now living with obesity, it is calling for increased and just availability to this class of drugs.

According to estimates, more than two billion are projected to be living with obesity by 2030 without intervention.

"The new guidelines affirms that obesity is a chronic disease that can be managed with thorough and continuous support," said the agency's head Tedros Adhanom Ghebreyesus.

Substantial prices, insufficient output, and distribution challenges are significant hurdles to widespread availability to the treatments that can aid individuals in losing considerable weight, notes the organization.

Skinny Jab Scarcity

Despite the present most optimistic scenario, the supply of GLP-1 therapies might only reach approximately 100 million people – less than 10% of those who need them, per the WHO.

The guideline urges countries and companies to expand access, through measures like licensing agreements.

Exclusive production rights on a key compound – the core ingredient of Novo Nordisk's Wegovy – is due to expire in several countries in 2026.

The Way Weight-Loss Injections Function

The injections imitate a natural hormone to slow digestion, suppress the appetite and increase the sense of being full so individuals consume fewer calories.

Individuals typically see weight reduction in the initial weeks of beginning the regular doses.

Research indicates patients may regain a significant portion a year later of halting the medication, as their usual food cravings return.

To be carrying excess weight increases your risk for contracting medical conditions, such as type 2 diabetes, cardiovascular issues, stroke, and some malignancies.

Excess weight affects individuals in countries worldwide and was linked to 3.7 million fatalities worldwide in 2024, per the health agency.

Maria Richards
Maria Richards

Marcus is a seasoned IT consultant with over 15 years of experience in software architecture and cybersecurity, sharing practical advice for tech professionals.